Chloroquine and hydroxychloroquine as available weapons to fight COVID-19.
作者信息
Colson Philippe, Rolain Jean-Marc, Lagier Jean-Christophe, Brouqui Philippe, Raoult Didier
机构信息
Aix-Marseille Université, Institut de Recherche pour le Développement (IRD), Assistance Publique-Hôpitaux de Marseille (AP-HM), MEPHI, 27 boulevard Jean Moulin, 13005 Marseille, France; IHU Méditerranée Infection, 19-21 boulevard Jean Moulin, 13005 Marseille, France.
Aix-Marseille Université, Institut de Recherche pour le Développement (IRD), Assistance Publique-Hôpitaux de Marseille (AP-HM), MEPHI, 27 boulevard Jean Moulin, 13005 Marseille, France; IHU Méditerranée Infection, 19-21 boulevard Jean Moulin, 13005 Marseille, France.
出版信息
Int J Antimicrob Agents. 2020 Apr;55(4):105932. doi: 10.1016/j.ijantimicag.2020.105932. Epub 2020 Mar 4.
Abstract
摘要
相似文献
1
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19.氯喹和羟氯喹作为对抗新型冠状病毒肺炎的现有武器。
Int J Antimicrob Agents. 2020 Apr;55(4):105932. doi: 10.1016/j.ijantimicag.2020.105932. Epub 2020 Mar 4.
2
Chloroquine and hydroxychloroquine for COVID-19: implications for cardiac safety.氯喹和羟氯喹用于治疗新型冠状病毒肺炎：对心脏安全性的影响
Eur Heart J Cardiovasc Pharmacother. 2020 Jul 1;6(4):256-257. doi: 10.1093/ehjcvp/pvaa041.
3
Chloroquine hype is derailing the search for coronavirus treatments.氯喹热潮正在扰乱对冠状病毒治疗方法的探索。
Nature. 2020 Apr;580(7805):573. doi: 10.1038/d41586-020-01165-3.
4
Audio Interview: Studying Potential Covid-19 Therapies.音频访谈：研究潜在的新冠病毒治疗方法。
N Engl J Med. 2020 May 7;382(19):e72. doi: 10.1056/NEJMe2015955.
5
To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic.在严重急性呼吸综合征冠状病毒2（新冠病毒）大流行中是否将抗疟药作为一种预防性干预措施加以考虑。
Ann Rheum Dis. 2020 May;79(5):666-667. doi: 10.1136/annrheumdis-2020-217367. Epub 2020 Apr 2.
6
[Chloroquine as a possible treatment for COVID-19].[氯喹作为新型冠状病毒肺炎的一种可能治疗方法]
Ned Tijdschr Geneeskd. 2020 Mar 11;164:D4936.
7
Are there any Therapeutic Options Currently Available for Wuhan Coronavirus?目前针对新型冠状病毒肺炎有哪些可用的治疗选择？
Antiinflamm Antiallergy Agents Med Chem. 2020;19(2):85-87. doi: 10.2174/1871523019999200228100917.
8
Audio Interview: New Data on Remdesivir in Covid-19.音频访谈：瑞德西韦治疗新冠病毒病的新数据
N Engl J Med. 2020 May 28;382(22):e94. doi: 10.1056/NEJMe2019975.
9
Coronavirus drugs trials must get bigger and more collaborative.冠状病毒药物试验必须扩大规模并加强合作。
Nature. 2020 May;581(7807):120. doi: 10.1038/d41586-020-01391-9.
10
Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug?我们用瑞德西韦（一种老药新包装）找到了治疗新冠病毒肺炎的万灵药了吗？
J R Coll Physicians Edinb. 2020 Jun;50(2):159-161. doi: 10.4997/JRCPE.2020.217.
引用本文的文献
1
COVID-19 and a Tale of Three Drugs: To Repurpose, or Not to Repurpose-That Was the Question.新冠疫情与三种药物的故事：是否进行药物再利用——这就是问题所在。
Viruses. 2025 Jun 23;17(7):881. doi: 10.3390/v17070881.
2
[Recommendations for rheumatologists on pharmacological management during the COVID-19 health emergency: Expert group opinion].[COVID-19 健康紧急状态下风湿病学家药物治疗管理建议：专家组意见]
Rev Colomb Reumatol. 2021 Apr-Jun;28(2):134-140. doi: 10.1016/j.rcreu.2020.05.021. Epub 2020 Jun 26.
3
Synthesis and anti-SARS-CoV-2 potential of novel coumarin hybrids: a combined wet/dry lab approach targeting M, Nsp15 and spike protein.新型香豆素杂化物的合成及其抗SARS-CoV-2潜力：一种针对M、Nsp15和刺突蛋白的湿/干实验室联合方法
RSC Adv. 2025 Jun 3;15(23):18577-18592. doi: 10.1039/d5ra02615f. eCollection 2025 May 29.
4
Malabaricone C isolated from edible plants as a potential inhibitor of SARS-CoV-2 infection.从可食用植物中分离出的马拉巴酮C作为一种潜在的新型冠状病毒感染抑制剂。
Sci Rep. 2025 Mar 12;15(1):8518. doi: 10.1038/s41598-024-83633-8.
5
Efficacy and Safety of Antimalarial as Repurposing Drug for COVID-19 Following Retraction of Chloroquine and Hydroxychloroquine.氯喹和羟氯喹撤稿后抗疟药作为COVID-19重新利用药物的疗效和安全性
Clin Pharmacol. 2025 Jan 16;17:1-11. doi: 10.2147/CPAA.S493750. eCollection 2025.
6
Repurposed Drugs during the Outbreak of Pandemic COVID-19: A Mini-Review on Their Molecular Structures and Hit-and-Trial Results.新冠大流行期间的药物再利用：关于其分子结构和试错结果的综述
ACS Omega. 2024 Aug 20;9(35):36858-36864. doi: 10.1021/acsomega.4c05357. eCollection 2024 Sep 3.
7
Mechanisms Underlying the Effects of Chloroquine on Red Blood Cells Metabolism.氯喹对红细胞代谢影响的作用机制。
Int J Mol Sci. 2024 Jun 11;25(12):6424. doi: 10.3390/ijms25126424.
8
Impact of COVID-19 Pandemic on Patients With Rheumatic Diseases in Medina, Saudi Arabia: An Observational Cross-Sectional Study.新冠疫情对沙特阿拉伯麦地那风湿性疾病患者的影响：一项观察性横断面研究
Cureus. 2024 May 12;16(5):e60128. doi: 10.7759/cureus.60128. eCollection 2024 May.
9
A high-throughput response to the SARS-CoV-2 pandemic.高通量应对 SARS-CoV-2 大流行。
SLAS Discov. 2024 Jul;29(5):100160. doi: 10.1016/j.slasd.2024.100160. Epub 2024 May 16.
10
[Pharmacological treatment of COVID-19: Narrative review of the Working Group in Infectious Diseases and Sepsis (GTEIS) and the Working Groups in Transfusions and Blood Products (GTTH)].[新型冠状病毒肺炎的药物治疗：传染病与脓毒症工作组（GTEIS）及输血与血液制品工作组（GTTH）的叙述性综述]
Med Intensiva. 2021 Mar;45(2):104-121. doi: 10.1016/j.medin.2020.06.017. Epub 2020 Jul 11.
本文引用的文献
1
[Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia].《磷酸氯喹治疗新型冠状病毒肺炎专家共识》
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Feb 20;43(0):E019. doi: 10.3760/cma.j.issn.1001-0939.2020.0019.
2
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.突破：磷酸氯喹在临床研究中显示出对 COVID-19 相关肺炎的明显疗效。
Biosci Trends. 2020 Mar 16;14(1):72-73. doi: 10.5582/bst.2020.01047. Epub 2020 Feb 19.
3
Chloroquine for the 2019 novel coronavirus SARS-CoV-2.氯喹用于2019新型冠状病毒SARS-CoV-2。
Int J Antimicrob Agents. 2020 Mar;55(3):105923. doi: 10.1016/j.ijantimicag.2020.105923. Epub 2020 Feb 15.
4
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.瑞德西韦和氯喹在体外能有效抑制新出现的新型冠状病毒（2019 - 新冠病毒）。
Cell Res. 2020 Mar;30(3):269-271. doi: 10.1038/s41422-020-0282-0. Epub 2020 Feb 4.
5
Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases.药物研发中的氯喹类似物：从疟疾到多种疾病的新应用方向、作用机制及毒性表现
J Antimicrob Chemother. 2015;70(6):1608-21. doi: 10.1093/jac/dkv018. Epub 2015 Feb 17.
6
Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture.对一个经美国食品药品监督管理局批准的化合物文库进行筛选，鉴定出四种在细胞培养中可抑制中东呼吸综合征冠状病毒复制的小分子抑制剂。
Antimicrob Agents Chemother. 2014 Aug;58(8):4875-84. doi: 10.1128/AAC.03011-14. Epub 2014 May 19.
7
Treatment of classic Whipple's disease: from in vitro results to clinical outcome.经典型 Whipple 病的治疗：从体外结果到临床结局。
J Antimicrob Chemother. 2014 Jan;69(1):219-27. doi: 10.1093/jac/dkt310. Epub 2013 Aug 14.
8
Effect of chloroquine on feline infectious peritonitis virus infection in vitro and in vivo.氯喹对猫传染性腹膜炎病毒感染的体外和体内影响。
Antiviral Res. 2013 Aug;99(2):100-7. doi: 10.1016/j.antiviral.2013.04.016. Epub 2013 May 3.
9
Antiviral activity of chloroquine against human coronavirus OC43 infection in newborn mice.氯喹对新生小鼠人冠状病毒OC43感染的抗病毒活性
Antimicrob Agents Chemother. 2009 Aug;53(8):3416-21. doi: 10.1128/AAC.01509-08. Epub 2009 Jun 8.
10
Inhibition of human coronavirus 229E infection in human epithelial lung cells (L132) by chloroquine: involvement of p38 MAPK and ERK.氯喹对人肺上皮细胞（L132）中人类冠状病毒229E感染的抑制作用：p38丝裂原活化蛋白激酶和细胞外信号调节激酶的参与
Antiviral Res. 2008 Feb;77(2):150-2. doi: 10.1016/j.antiviral.2007.10.011. Epub 2007 Nov 20.
Zotero 插件